FDA Inspection 1260263 — SIGVARIS AG
The FDA completed an inspection of SIGVARIS AG on Jan 16, 2025 in Saint Gall. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 16, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Saint Gall (Switzerland)